Reset filter
Nyckelord
D016430 ×
Visa mer Nyckelord
Innehållsförteckning
  1. 1. Klinisk studie
  2. 2. Rutindokumentation
  3. 3. Register- och kohortstudier
  4. 4. Kvalitetssäkring
  5. 5. Datastandard
  6. 6. Frågeformulär för patienter
  7. 7. Medicinsk specialitet
    1. 7.1. Anestesi
    1. 7.2. Dermatologi
    1. 7.3. HNO
    1. 7.4. Geriatrik
    1. 7.5. Gynekologi och obstetrik
    1. 7.6. Invärtes medicin
      1. Hematologi
      1. Infektionssjukdomar
      1. Kardiologi och angiologi
      1. Pneumologi
      1. Gastroenterologi
      1. Nefrologi
      1. Endokrinologi och ämnesomsättning
      1. Reumatologi
    1. 7.7. Neurologi
    1. 7.8. Oftalmologi
    1. 7.9. Palliativ medicin
    1. 7.10. Patologi och rättsmedicin
    1. 7.11. Pediatrik
    1. 7.12. Psykiatri och psykosomatik
    1. 7.13. Radiologi
    1. 7.14. Kirurgi
      1. Allmänkirurgi och bukkirurgi
      1. Neurokirurgi
      1. Plastikkirurgi
      1. Hjärt- och thoraxkirurgi
      1. Akutkirurgi och ortopedi
      1. Kärlkirurgi
    1. 7.15. Urologi
    1. 7.16. Odontologi samt mun-, käk och ansiktskirurgi
Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

7189 Sökresultat.
Relevans Bedömning Nya först Gamla först

Screening: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 16 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Screening

Baseline: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 15 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Baseline If already performed at screening, please enter results of screening MRI.

CHEST X-RAY (AP AND LATERAL) Roche H0650g Breast Cancer - CHEST X-RAY (AP AND LATERAL)

- 2017-05-16 - 1 Formulär, 1 Item-grupp, 5 Dataelement, 1 Språk
Item-grupp: Chest X-Ray
Study part: Chest X- ray. A phase III multinational, randomized, single-blind study of recombinant humanized anti-p185HER2 monoclonal antibody (rhuMAb HER2) in patients with HER2/neu overexpression who have not received prior cytotoxic chemotherapy for metastatic breast cancer. "Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche"

Melanoma (Skin) null Registration - Chest X-ray Report Shuttle (CXRS) - 2074545v3.0 - Chest X-ray Report Shuttle (CXRS)

- 2015-01-09 - 1 Formulär, 1 Item-grupp, 4 Dataelement, 1 Språk
Item-grupp: CCRR MODULE
Chest X-ray Report Shuttle (CXRS) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1232AA1-F528-4C83-E034-0003BA12F5E7

Discontinuation Visit: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 14 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Discontinuation Visit

Month 36: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 14 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Month 36

Month 12: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 14 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Month 12

Month 18: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 14 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Month 18

Month 30: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 14 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Month 30

Month 24: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 14 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Month 24

Month 6: MRI Multiple Sclerosis ALAIN01 NCT02419378

- 2016-06-03 - 1 Formulär, 1 Item-grupp, 14 Dataelement, 1 Språk
Item-grupp: MRI
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Month 6

Eligibility Multiple Sclerosis NCT02485223

- 2019-05-19 - 1 Formulär, 2 Item-grupper, 9 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT02485223

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial